EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Given Consensus Recommendation of “Buy” by Analysts

Shares of EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) have been assigned a consensus rating of “Buy” from the eight analysts that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, five have given a buy recommendation and two have given a strong buy recommendation to the company.

ESLOY has been the topic of a number of research analyst reports. Kepler Capital Markets upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Thursday, January 15th. UBS Group upgraded EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 27th. Citigroup reissued a “buy” rating on shares of EssilorLuxottica in a research report on Thursday, December 11th. Zacks Research lowered EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Finally, HSBC raised shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Wednesday, January 14th.

EssilorLuxottica Stock Down 5.8%

EssilorLuxottica stock opened at $133.00 on Tuesday. EssilorLuxottica has a fifty-two week low of $126.47 and a fifty-two week high of $186.81. The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.67 and a current ratio of 0.97. The firm’s 50-day simple moving average is $153.65 and its 200 day simple moving average is $162.95.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.